Devy Deliyanti

1.4k total citations
34 papers, 1.1k citations indexed

About

Devy Deliyanti is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Devy Deliyanti has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Ophthalmology, 13 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Immunology. Recurrent topics in Devy Deliyanti's work include Retinal Diseases and Treatments (16 papers), Retinopathy of Prematurity Studies (10 papers) and Neuroinflammation and Neurodegeneration Mechanisms (7 papers). Devy Deliyanti is often cited by papers focused on Retinal Diseases and Treatments (16 papers), Retinopathy of Prematurity Studies (10 papers) and Neuroinflammation and Neurodegeneration Mechanisms (7 papers). Devy Deliyanti collaborates with scholars based in Australia, United Kingdom and United States. Devy Deliyanti's co-authors include Jennifer L. Wilkinson‐Berka, Alex Agrotis, Antonia G. Miller, William A. Figgett, Fabienne Mackay, Judy B. de Haan, Sih Min Tan, Karin Jandeleit‐Dahm, Katrina J. Binger and Mark E. Cooper and has published in prestigious journals such as Nature Communications, Journal of Neuroscience and Immunity.

In The Last Decade

Devy Deliyanti

33 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Devy Deliyanti Australia 23 447 332 284 225 186 34 1.1k
Tahira Lemtalsi United States 17 400 0.9× 391 1.2× 211 0.7× 127 0.6× 188 1.0× 33 1.0k
Youde Jiang United States 20 466 1.0× 488 1.5× 184 0.6× 107 0.5× 153 0.8× 59 1.0k
Elena Beltramo Italy 20 440 1.0× 424 1.3× 98 0.3× 196 0.9× 156 0.8× 39 1.3k
Takashi Koto Japan 19 819 1.8× 447 1.3× 107 0.4× 524 2.3× 206 1.1× 62 1.5k
Shingo Satofuka Japan 14 537 1.2× 415 1.3× 113 0.4× 199 0.9× 80 0.4× 26 1.1k
Sampathkumar Rangasamy United States 20 927 2.1× 611 1.8× 149 0.5× 565 2.5× 192 1.0× 44 1.9k
Qinghua Qiu China 22 686 1.5× 694 2.1× 152 0.5× 411 1.8× 131 0.7× 71 1.6k
Lalit P. Singh United States 23 415 0.9× 1.1k 3.2× 129 0.5× 121 0.5× 128 0.7× 42 1.7k
Finny Monickaraj United States 18 421 0.9× 273 0.8× 97 0.3× 222 1.0× 109 0.6× 27 928
Yuko Jinnouchi Japan 14 234 0.5× 287 0.9× 131 0.5× 52 0.2× 121 0.7× 17 989

Countries citing papers authored by Devy Deliyanti

Since Specialization
Citations

This map shows the geographic impact of Devy Deliyanti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devy Deliyanti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devy Deliyanti more than expected).

Fields of papers citing papers by Devy Deliyanti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devy Deliyanti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devy Deliyanti. The network helps show where Devy Deliyanti may publish in the future.

Co-authorship network of co-authors of Devy Deliyanti

This figure shows the co-authorship network connecting the top 25 collaborators of Devy Deliyanti. A scholar is included among the top collaborators of Devy Deliyanti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Devy Deliyanti. Devy Deliyanti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Deliyanti, Devy, et al.. (2023). Early Depletion of Neutrophils Reduces Retinal Inflammation and Neovascularization in Mice with Oxygen-Induced Retinopathy. International Journal of Molecular Sciences. 24(21). 15680–15680. 8 indexed citations
3.
Deliyanti, Devy, William A. Figgett, Thomas Gebhardt, et al.. (2023). CD8 + T Cells Promote Pathological Angiogenesis in Ocular Neovascular Disease. Arteriosclerosis Thrombosis and Vascular Biology. 43(4). 522–536. 22 indexed citations
4.
5.
Wickramasinghe, Lakshanie C., Devy Deliyanti, Peter van Wijngaarden, et al.. (2020). Lung and Eye Disease Develop Concurrently in Supplemental Oxygen–Exposed Neonatal Mice. American Journal Of Pathology. 190(9). 1801–1812. 13 indexed citations
6.
Wilkinson‐Berka, Jennifer L., et al.. (2020). The role of reactive oxygen species in the pathogenesis and treatment of retinal diseases. Experimental Eye Research. 201. 108255–108255. 45 indexed citations
7.
Lee, Jae Young, Viola Oorschot, Georg Ramm, et al.. (2019). Limiting Neuronal Nogo Receptor 1 Signaling during Experimental Autoimmune Encephalomyelitis Preserves Axonal Transport and Abrogates Inflammatory Demyelination. Journal of Neuroscience. 39(28). 5562–5580. 13 indexed citations
8.
Rana, Indrajeetsinh, et al.. (2019). Angiotensin II and aldosterone activate retinal microglia. Experimental Eye Research. 191. 107902–107902. 32 indexed citations
9.
Deliyanti, Devy, Sih Min Tan, Colin J. Meyer, et al.. (2018). Nrf2 Activation Is a Potential Therapeutic Approach to Attenuate Diabetic Retinopathy. Investigative Ophthalmology & Visual Science. 59(2). 815–815. 65 indexed citations
10.
Deliyanti, Devy, et al.. (2017). Endothelin-2 Injures the Blood–Retinal Barrier and Macroglial Müller Cells. American Journal Of Pathology. 188(3). 805–817. 23 indexed citations
11.
Deliyanti, Devy, Tong Zhu, Mhairi J. Maxwell, et al.. (2017). Foxp3+ Tregs are recruited to the retina to repair pathological angiogenesis. Nature Communications. 8(1). 748–748. 73 indexed citations
12.
Figgett, William A., et al.. (2015). Deleting the BAFF receptor TACI protects against systemic lupus erythematosus without extensive reduction of B cell numbers. Journal of Autoimmunity. 61. 9–16. 38 indexed citations
13.
Deliyanti, Devy & Jennifer L. Wilkinson‐Berka. (2015). Inhibition of NOX1/4 with GKT137831: a potential novel treatment to attenuate neuroglial cell inflammation in the retina. Journal of Neuroinflammation. 12(1). 136–136. 66 indexed citations
14.
Deliyanti, Devy, et al.. (2015). FT011, a Novel Cardiorenal Protective Drug, Reduces Inflammation, Gliosis and Vascular Injury in Rats with Diabetic Retinopathy. PLoS ONE. 10(7). e0134392–e0134392. 15 indexed citations
15.
Tan, Sih Min, et al.. (2015). Ebselen by modulating oxidative stress improves hypoxia-induced macroglial Müller cell and vascular injury in the retina. Experimental Eye Research. 136. 1–8. 40 indexed citations
16.
Deliyanti, Devy, et al.. (2014). Retinal Vasculopathy Is Reduced by Dietary Salt Restriction. Arteriosclerosis Thrombosis and Vascular Biology. 34(9). 2033–2041. 23 indexed citations
17.
Wilkinson‐Berka, Jennifer L., Devy Deliyanti, Indrajeetsinh Rana, et al.. (2013). NADPH Oxidase, NOX1, Mediates Vascular Injury in Ischemic Retinopathy. Antioxidants and Redox Signaling. 20(17). 2726–2740. 105 indexed citations
18.
Figgett, William A., Kirsten A. Fairfax, Fabien B. Vincent, et al.. (2013). The TACI Receptor Regulates T-Cell-Independent Marginal Zone B Cell Responses through Innate Activation-Induced Cell Death. Immunity. 39(3). 573–583. 50 indexed citations
19.
Wilkinson‐Berka, Jennifer L., Alex Agrotis, & Devy Deliyanti. (2012). The retinal renin–angiotensin system: Roles of angiotensin II and aldosterone. Peptides. 36(1). 142–150. 73 indexed citations
20.
Wilkinson‐Berka, Jennifer L., Genevieve Tan, Katrina J. Binger, et al.. (2011). Aliskiren reduces vascular pathology in diabetic retinopathy and oxygen-induced retinopathy in the transgenic (mRen-2)27 rat. Diabetologia. 54(10). 2724–2735. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tahira Lemtalsi Breakdown of academic impact, for papers by Youde Jiang Breakdown of academic impact, for papers by Elena Beltramo Breakdown of academic impact, for papers by Takashi Koto Breakdown of academic impact, for papers by Shingo Satofuka Breakdown of academic impact, for papers by Sampathkumar Rangasamy Breakdown of academic impact, for papers by Qinghua Qiu Breakdown of academic impact, for papers by Lalit P. Singh Breakdown of academic impact, for papers by Finny Monickaraj Breakdown of academic impact, for papers by Yuko Jinnouchi
Rankless by CCL
2026